Application no. and date | 13709190.6 (espacenet) (Federated) (European Patent Register), 20130312 | Patent/reg. no. and date | DK/EP 2825555, 20170712 | Publication date | 20150121 | Priority no. and date | US 201261610030 P, 20120313, EP 12159276, 20120313 | EP pub. no. and date |
EP 2825555 20150121 | Effective date | | Applicant/owner | Octapharma AG, Seidenstrasse 2
8853 Lachen, CH | Applicant ref. no. | | Inventor | SCHULZ, Petra, c/o Octapharma PPGmbh Oberlaaer Str. 235
A-1100 Vienna, AT, GEHRINGER, Werner, c/o Octapharma PPGmbh Oberlaaer Str. 235
A-1100 Vienna, AT, PAPE, Rainer, c/o Octapharma PPGmbH Oberlaaer Str. 235
A-1100 Vienna, AT, LEITINGER, Caroline, c/o Octapharma PPGmbH Oberlaaer Str. 235
A-1100 Vienna, AT, SCHÖN, Friedrich, c/o Octapharma PPGmbH Oberlaaer Str. 235
A-1100 Vienna, AT, RÖMISCH, Jürgen, c/o Octapharma PPGmbH Oberlaaer Str. 235
A-1100 Vienna, AT | Representative | | Opponent | | IPC Class | C07K 14/75 (2006.01) | Title | IMPROVED PROCESS FOR PRODUCTION OF FIBRINOGEN AND FIBRINOGEN PRODUCED THEREBY | Int. application no. | EP2013054983 | Int. publication no. | WO2013135684 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|